Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease

NCT ID: NCT06081205

Last Updated: 2023-10-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-27

Study Completion Date

2027-04-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a registry of the patients that are admitted to CICU and treated by the Scientific Staff of the 2nd Department of Cardiology, due to an acute cardiovascular disease (acute coronary syndrome, acute heart failure, arrhythmia, pulmonary embolism, cardiac tamponade etc) in order to investigate the clinical characteristics of the patients, their outcome, identify the factors that could predict the in-hospital mortality and compare the results with the predicted by established risk scores. Furthermore, the study will investigate the one-year mortality and also the major adverse cardiac events (MACE - acute myocardial infarction, stroke, or cardiovascular death) will be measured.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For every patient that will be enrolled to the study, information from the medical record will be collected, as long as he/she has provided a signed consent form after being fully informed of the study and its objectives. In case the patient cannot decide on his/her own, e.g. intubated patients, an informed consent form must be acquired by a relative or legal representative. Only the data that will be considered necessary for scientific reasons will be acquired: general and demographic information, medical information like the personal and family history, the diagnostic tests performed and the treatments or interventions that took place. The patients will not have to do anything further or undergo any additional visits or medical exams apart from those indicated; they will not receive any extra treatment (because of their participation to the study) beyond what they would receive for their condition according to the established practice so far. Furthermore, the doctor will not change or withdraw any treatment that the patients would normally receive. The patients' medical care will continue normally under the CICU doctors' supervision.

The participants will be monitored during their hospitalization in the CICU, during their hospitalization in the 2nd Department of Cardiology of the UHI after their discharge from CICU, as well as for the next 1-year in the Outpatients Clinic; if the latter is not feasible (in case of disability or distance) they will be contacted through telephone interviews.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiogenic Shock Acute Decompensated Heart Failure Acute Pulmonary Embolism Acute Myocardial Infarction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Admission in the Cardiac Intensive Care Unit (CICU)

all patients admitted in the CICU will be enrolled in the study provided they give their informed consent.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

no further interventions

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients admitted to the Cardiac Intensive Care Unit (CICU) through the Emergency Department of the UHI
* All patients transferred to the CICU from other hospital departments or other regional secondary hospitals
* Patients with an acute cardiovascular disease that requires treatment in a CICU
* Patients who are under scientific supervision of the 2nd Department of Cardiology
* Patients (or their relative/legal representatives) that have signed the informed consent form
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Ioannina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Katerina Naka

Professor of Cardiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lampros K Michalis, MD, PhD

Role: STUDY_DIRECTOR

Professor of Cardiology, Director of the 2nd Cardiology Department, University Hospital of Ioannina

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital of Ioannina

Ioannina, Epirus, Greece

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Greece

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Katerina K Naka, MD, PhD

Role: CONTACT

+30 26510 99111 ext. 039

Aidonis Rammos, MD

Role: CONTACT

+30 26510 99111 ext. 347

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aidonis Rammos, MD

Role: primary

+3026510 99111 ext. 347

Konstantinos Siaravas, MD

Role: backup

+3026510 99111 ext. 863

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10/270423

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Altshock-2 REGISTRY
NCT04295252 RECRUITING